NO307406B1 - Anvendelse av 1-aryl-3-(4-piperidyl)-indolderivater ved behandling av kognitive forstyrrelser - Google Patents

Anvendelse av 1-aryl-3-(4-piperidyl)-indolderivater ved behandling av kognitive forstyrrelser

Info

Publication number
NO307406B1
NO307406B1 NO933091A NO933091A NO307406B1 NO 307406 B1 NO307406 B1 NO 307406B1 NO 933091 A NO933091 A NO 933091A NO 933091 A NO933091 A NO 933091A NO 307406 B1 NO307406 B1 NO 307406B1
Authority
NO
Norway
Prior art keywords
piperidyl
aryl
treatment
cognitive disorders
indole derivatives
Prior art date
Application number
NO933091A
Other languages
English (en)
Norwegian (no)
Other versions
NO933091D0 (no
NO933091L (no
Inventor
Jens Kristian Perregaard
Brenda Costall
Original Assignee
Lundbeck & Co As H
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lundbeck & Co As H filed Critical Lundbeck & Co As H
Publication of NO933091D0 publication Critical patent/NO933091D0/no
Publication of NO933091L publication Critical patent/NO933091L/no
Publication of NO307406B1 publication Critical patent/NO307406B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Processing Of Meat And Fish (AREA)
NO933091A 1991-03-01 1993-08-31 Anvendelse av 1-aryl-3-(4-piperidyl)-indolderivater ved behandling av kognitive forstyrrelser NO307406B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DK036291A DK36291D0 (da) 1991-03-01 1991-03-01 Anvendelse af piperidylsubstituerede indolderivater til behandling af kognitive lidelser
PCT/DK1992/000063 WO1992015303A1 (fr) 1991-03-01 1992-02-28 Traitement de troubles cognitifs

Publications (3)

Publication Number Publication Date
NO933091D0 NO933091D0 (no) 1993-08-31
NO933091L NO933091L (no) 1993-11-01
NO307406B1 true NO307406B1 (no) 2000-04-03

Family

ID=8092662

Family Applications (1)

Application Number Title Priority Date Filing Date
NO933091A NO307406B1 (no) 1991-03-01 1993-08-31 Anvendelse av 1-aryl-3-(4-piperidyl)-indolderivater ved behandling av kognitive forstyrrelser

Country Status (16)

Country Link
US (1) US5444073A (fr)
EP (1) EP0575429B1 (fr)
JP (1) JP3108434B2 (fr)
KR (1) KR0183424B1 (fr)
AT (1) ATE131055T1 (fr)
AU (1) AU663699B2 (fr)
CA (1) CA2105385C (fr)
CY (1) CY2083B1 (fr)
DE (1) DE69206607T2 (fr)
DK (2) DK36291D0 (fr)
IE (1) IE70600B1 (fr)
IL (1) IL101102A (fr)
NO (1) NO307406B1 (fr)
NZ (1) NZ241800A (fr)
WO (1) WO1992015303A1 (fr)
ZA (1) ZA921462B (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5468768A (en) * 1994-01-06 1995-11-21 Bristol-Myers Squibb Company Antimigraine derivatives of indolylcycloalkanylamines
US6489341B1 (en) 1999-06-02 2002-12-03 Sepracor Inc. Methods for the treatment of neuroleptic and related disorders using sertindole derivatives
ES2685780T3 (es) 2002-08-22 2018-10-11 Sumitomo Dainippon Pharma Co., Ltd. Agente para el tratamiento de esquizofrenia
CN1826338B (zh) * 2003-06-23 2011-07-13 大日本住友制药株式会社 老年性痴呆症治疗药
WO2005080976A1 (fr) 2004-02-20 2005-09-01 Dainippon Sumitomo Pharma Co., Ltd. Procédé de recherche par criblage in vivo d'un agent thérapeutique pour un dysfonctionnement de la mémoire/de l'apprentissage par schizophrénie
US20070212412A1 (en) * 2005-09-08 2007-09-13 H. Lundbeck A/S Stable solid formulation of sertindole
TW200821296A (en) * 2006-06-01 2008-05-16 Lundbeck & Co As H Use of sertindole for the preventive treatment of suicidal behaviour
US8258139B2 (en) 2010-11-08 2012-09-04 Dainippon Sumitomo Pharma Co., Ltd. Method of treatment for mental disorders

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL48508A (en) * 1974-12-09 1979-10-31 Roussel Uclaf Pharmaceutical compositions comprising piperidylindole derivatives
FR2362628A1 (fr) * 1976-08-26 1978-03-24 Roussel Uclaf Nouveaux derives du piperidyl-indole et leurs sels, procede de preparation et application a titre de medicaments
SE8004129L (sv) * 1979-07-13 1981-01-14 Roussel Uclaf Nya tetrahydropyridin-4-yl-indolderivat samt salter derav, framstellning och anvendning derav sasom lekemedel samt kompositioner innehallande dessa foreningar
IE58370B1 (en) * 1985-04-10 1993-09-08 Lundbeck & Co As H Indole derivatives
GB8704572D0 (en) * 1987-02-26 1987-04-01 Lundbeck & Co As H Organic compounds
DK158590D0 (da) * 1990-07-02 1990-07-02 Lundbeck & Co As H Indolderivater

Also Published As

Publication number Publication date
ZA921462B (en) 1992-11-25
NZ241800A (en) 1997-03-24
DK0575429T3 (da) 1996-04-22
DE69206607T2 (de) 1996-05-15
JP3108434B2 (ja) 2000-11-13
AU663699B2 (en) 1995-10-19
CA2105385C (fr) 2000-08-15
KR0183424B1 (ko) 1999-05-01
IL101102A0 (en) 1992-11-15
US5444073A (en) 1995-08-22
AU1370792A (en) 1992-10-06
WO1992015303A1 (fr) 1992-09-17
JPH06504787A (ja) 1994-06-02
NO933091D0 (no) 1993-08-31
HK1003560A1 (en) 1998-10-30
CY2083B1 (en) 1998-10-16
CA2105385A1 (fr) 1992-09-02
IE70600B1 (en) 1996-12-11
IL101102A (en) 1996-03-31
DE69206607D1 (de) 1996-01-18
DK36291D0 (da) 1991-03-01
ATE131055T1 (de) 1995-12-15
EP0575429A1 (fr) 1993-12-29
EP0575429B1 (fr) 1995-12-06
NO933091L (no) 1993-11-01
KR930702978A (ko) 1993-11-29
IE920572A1 (en) 1992-09-09

Similar Documents

Publication Publication Date Title
NO974163L (no) Ester av 5-aminolevulinsyre som fotosensibiliserings-middel i fotokjemoterapi
DK275488A (da) Indolonderivater
RU93055870A (ru) Производные бифенила, способ их получения и фармацевтическая композиция для лечения гипертонии и сердечных заболеваний
EP0376899A3 (fr) Utilisation des dérivés de la L-carnitine pour la fabrication d'un médicament pour le traitement thérapeutique des neuropathies pêriphériques
NO933091L (no) Anvendelse av 1-aryl-3-(4-piperidyl)-indolderivater ved behandling av kognitive forstyrrelser
ES2053668T3 (es) Derivados de poliamina como agentes antineoplasicos.
ZA922910B (en) Heterocylic pharmaceutical compounds preparation and use
FR2458556B1 (fr)
CA2289017A1 (fr) Utilisation d'oxydes d'azote ou de promedicament a base de ces oxydes pour la prevention et le traitement therapeutique du cancer
SE9702716D0 (sv) Substituted phenylazacycloalkanes in the treatment of cognitive disorders
FI96308C (fi) Menetelmä terapeuttisesti käyttökelpoisten 9-aminotetrahydroakridiinien ja niiden johdannaisten valmistamiseksi
MY133438A (en) Morpholinobenzamide salts
PT1082116E (pt) Utilizacao de derivados de 4-piperidinometanol no tratamento de desordens do neurodesenvolvimento
NO173783C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive, kondenserte heterodykliske derivater av 1,2,3,4-tetrahydroakridiner
SE8302452D0 (sv) Method for treatment of senile dementia
NO974101D0 (no) Anvendelse av penciclovir for behandling av human herpes virus-8
US6541495B1 (en) Carboxylic acid derivatives as inhibitors of hyperproliferation diseases
KR940018387A (ko) 위장 장애와 궤양 유발이 현저히 감소된 케토롤락 유도체
NO961180L (no) Transdermal anordning inneholdende (E)-2-(p-fluorfenetyl)-3-fluorallylamin for behandling av Alzheimers sykdom

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees